FierceBiotech3d
AbbVie exercises first $40M option to advance Capsida-partnered CNS gene therapy
Gene therapy firm Capsida Biotherapeutics is advancing the first of its AbbVie-partnered neurodegenerative disease therapies ...
Capsida Announces AbbVie Opt-in for First Genetic Medicine Program from Neurodegenerative Disease Collaboration
Capsida Biotherapeutics ("Capsida") today announced that AbbVie has exercised an option for the first neurodegenerative ...
The Pharma Letter2d
AbbVie opts in for first genetic medicine program with Capsida
Capsida Biotherapeutics yesterday revealed US pharma major AbbVie has exercised an option for the first neurodegenerative ...
The Victoria Advocate23d
Capsida Biotherapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
In addition to its wholly owned programs, the Company has validating partnerships with AbbVie, Lilly, and CRISPR Therapeutics. Capsida was founded in 2019 by lead investors Versant Ventures and ...
The Business Journals29d
AbbVie to buy Madison pharmaceutical tech firm for $200 million
Pharmaceutical giant AbbVie Inc. has agreed to acquire Madison's Nimble Therapeutics Inc. for $200 million in cash. Pharmaceutical giant AbbVie Inc. has agreed to acquire Madison's Nimble ...